125 related articles for article (PubMed ID: 35063488)
21. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.
Feng H; Li B; Li Z; Wei Q; Ren L
BMC Cancer; 2021 Apr; 21(1):401. PubMed ID: 33849479
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of alpha-fetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels.
Xu WJ; Guo BL; Han YG; Shi L; Ma WS
Tumour Biol; 2014 Dec; 35(12):12069-74. PubMed ID: 25209179
[TBL] [Abstract][Full Text] [Related]
23. Nanobody medicated immunoassay for ultrasensitive detection of cancer biomarker alpha-fetoprotein.
Chen J; He QH; Xu Y; Fu JH; Li YP; Tu Z; Wang D; Shu M; Qiu YL; Yang HW; Liu YY
Talanta; 2016 Jan; 147():523-30. PubMed ID: 26592642
[TBL] [Abstract][Full Text] [Related]
24. Phosphate-triggered ratiometric fluoroimmunoassay based on nanobody-alkaline phosphatase fusion for sensitive detection of 1-naphthol for the exposure assessment of pesticide carbaryl.
Chen ZJ; Wu HL; Shen YD; Wang H; Zhang YF; Hammock B; Li ZF; Luo L; Lei HT; Xu ZL
J Hazard Mater; 2022 Feb; 424(Pt C):127411. PubMed ID: 34629198
[TBL] [Abstract][Full Text] [Related]
25. [Value of alpha 1-fetoprotein (AFP) determination with an ultramicro-ELISA immunoassay in chronic liver diseases with special reference to hepatocellular cancer].
Reinhardt M; Schulze M; Machnik G; Jorke D; Laske V; Krombholz B; Kappauf G; Schröder S
Dtsch Z Verdau Stoffwechselkr; 1987; 47(5):230-41. PubMed ID: 2449324
[TBL] [Abstract][Full Text] [Related]
26. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma].
Sun GZ; Zhao XY; Li JH; Zhao GQ; Wang SX; Kong SL
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1986-8. PubMed ID: 19062741
[TBL] [Abstract][Full Text] [Related]
27. Development of a nanobody-alkaline phosphatase fusion protein and its application in a highly sensitive direct competitive fluorescence enzyme immunoassay for detection of ochratoxin A in cereal.
Liu X; Xu Y; Wan DB; Xiong YH; He ZY; Wang XX; Gee SJ; Ryu D; Hammock BD
Anal Chem; 2015 Jan; 87(2):1387-94. PubMed ID: 25531426
[TBL] [Abstract][Full Text] [Related]
28. Development of Shark Single Domain Antibodies Specific for Human α-Fetoprotein and the Multimerization Strategy in Serum Detection.
Wang Z; Xie X; He Z; Sun Z; Zhang Y; Mao F; Pei H; Zhang S; Hammock BD; Liu X
Anal Chem; 2024 Mar; 96(10):4242-4250. PubMed ID: 38408370
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels.
Kang SH; Kim DY; Jeon SM; Ahn SH; Park JY; Kim SU; Kim JK; Lee KS; Chon CY; Han KH
Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):849-56. PubMed ID: 22495400
[TBL] [Abstract][Full Text] [Related]
30. Value of serum alpha-fetoprotein and ferritin in the diagnosis of hepatocellular carcinoma.
Tatsuta M; Yamamura H; Iishi H; Kasugai H; Okuda S
Oncology; 1986; 43(5):306-10. PubMed ID: 2429242
[TBL] [Abstract][Full Text] [Related]
31. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS
Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
[TBL] [Abstract][Full Text] [Related]
32. Generation of Dual functional Nanobody-Nanoluciferase Fusion and its potential in Bioluminescence Enzyme Immunoassay for trace Glypican-3 in Serum.
Yu S; Li Z; Li J; Zhao S; Wu S; Liu H; Bi X; Li D; Dong J; Duan S; Hammock BD
Sens Actuators B Chem; 2021 Jun; 336():. PubMed ID: 35250176
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
Choi JY; Jung SW; Kim HY; Kim M; Kim Y; Kim DG; Oh EJ
World J Gastroenterol; 2013 Jan; 19(3):339-46. PubMed ID: 23372355
[TBL] [Abstract][Full Text] [Related]
34. Development of high-performance magnetic chemiluminescence enzyme immunoassay for alpha-fetoprotein (AFP) in human serum.
Wang X; Zhang QY; Li ZJ; Ying XT; Lin JM
Clin Chim Acta; 2008 Jul; 393(2):90-4. PubMed ID: 18402780
[TBL] [Abstract][Full Text] [Related]
35. The characteristics of hepatocellular carcinoma with a high level of serum lactic dehydrogenase: a case report.
Fujiwara Y; Takenaka K; Kajiyama K; Maeda T; Gion T; Shirabe K; Shimada M; Sugimachi K
Hepatogastroenterology; 1997; 44(15):820-3. PubMed ID: 9222698
[TBL] [Abstract][Full Text] [Related]
36. A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.
El-Serag HB; Kanwal F; Davila JA; Kramer J; Richardson P
Gastroenterology; 2014 May; 146(5):1249-55.e1. PubMed ID: 24462733
[TBL] [Abstract][Full Text] [Related]
37.
Lee HA; Lee YR; Lee YS; Jung YK; Kim JH; An H; Yim HJ; Jeen YT; Yeon JE; Byun KS; Seo YS
World J Gastroenterol; 2021 Jul; 27(28):4687-4696. PubMed ID: 34366629
[TBL] [Abstract][Full Text] [Related]
38. Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage.
Luo P; Wu S; Yu Y; Ming X; Li S; Zuo X; Tu J
Pathol Oncol Res; 2020 Apr; 26(2):599-603. PubMed ID: 30661224
[TBL] [Abstract][Full Text] [Related]
39. [Serum anti-Ku86: a potential biomarker for early detection of hepatocellular carcinoma].
Chu L; Zhang X; Wang G; Zhou W; Du Z; Liu A; Zhao H
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):123-7. PubMed ID: 24796461
[TBL] [Abstract][Full Text] [Related]
40. Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma.
Wang T; Liu M; Zheng SJ; Bian DD; Zhang JY; Yao J; Zheng QF; Shi AM; Li WH; Li L; Chen Y; Wang JH; Duan ZP; Dong L
World J Gastroenterol; 2017 May; 23(19):3496-3504. PubMed ID: 28596685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
